IFNA2 and hepatitis C virus infection: A pro-apoptotic effect of Ocoxin on activated HSC could explain some of the beneficial outcomes found in clinical studies carried out with hepatitis C patients, in which treatment with Ocoxin either by itself [9] or combined with interferon alpha-2b and ribavirin caused a reduction of fibrosis [32].